Natera, Inc. (NASDAQ:NTRA) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas cut its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 58.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,335 shares of the medical research company's stock after selling 25,358 shares during the quarter. Teacher Retirement System of Texas' holdings in Natera were worth $2,593,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Private Trust Co. NA increased its holdings in shares of Natera by 780.1% during the first quarter. Private Trust Co. NA now owns 1,461 shares of the medical research company's stock valued at $207,000 after acquiring an additional 1,295 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd acquired a new position in shares of Natera during the first quarter valued at about $1,851,000. Amalgamated Bank increased its holdings in shares of Natera by 9.8% during the first quarter. Amalgamated Bank now owns 8,293 shares of the medical research company's stock valued at $1,173,000 after acquiring an additional 740 shares in the last quarter. K.J. Harrison & Partners Inc increased its holdings in shares of Natera by 45.5% during the first quarter. K.J. Harrison & Partners Inc now owns 12,800 shares of the medical research company's stock valued at $1,810,000 after acquiring an additional 4,000 shares in the last quarter. Finally, Colonial River Investments LLC acquired a new position in shares of Natera during the first quarter valued at about $441,000. 99.90% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Steven Leonard Chapman sold 6,980 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $150.10, for a total transaction of $1,047,698.00. Following the transaction, the chief executive officer owned 185,182 shares in the company, valued at $27,795,818.20. This trade represents a 3.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Gail Boxer Marcus sold 4,299 shares of the stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $167.36, for a total value of $719,480.64. Following the transaction, the director owned 8,118 shares in the company, valued at $1,358,628.48. This trade represents a 34.62% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 53,272 shares of company stock worth $8,345,368 in the last quarter. Corporate insiders own 7.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on NTRA. Wall Street Zen downgraded shares of Natera from a "hold" rating to a "sell" rating in a report on Saturday, May 17th. Barclays upped their price objective on shares of Natera from $160.00 to $190.00 and gave the company an "overweight" rating in a report on Friday, May 9th. UBS Group upped their target price on Natera from $211.00 to $218.00 and gave the company a "buy" rating in a research report on Friday, May 9th. Finally, Piper Sandler upped their target price on Natera from $205.00 to $210.00 and gave the company an "overweight" rating in a research report on Thursday, May 15th. One analyst has rated the stock with a sell rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $184.63.

Natera Trading Down 1.8%

Natera stock traded down $2.93 during mid-day trading on Friday, hitting $160.43. The company had a trading volume of 710,024 shares, compared to its average volume of 1,423,140. Natera, Inc. has a 12-month low of $92.14 and a 12-month high of $183.00. The company's fifty day moving average is $161.05 and its 200-day moving average is $158.41. The company has a market capitalization of $21.91 billion, a price-to-earnings ratio of -109.14 and a beta of 1.73.

Natera (NASDAQ:NTRA - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical research company reported ($0.50) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.59) by $0.09. Natera had a negative return on equity of 18.29% and a negative net margin of 10.36%. The firm had revenue of $501.83 million for the quarter, compared to analyst estimates of $446.68 million. During the same quarter last year, the firm posted ($0.56) EPS. The business's revenue was up 36.5% on a year-over-year basis. As a group, sell-side analysts expect that Natera, Inc. will post -1.49 EPS for the current fiscal year.

Natera Company Profile

Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.